Rapid HIV Testing and Counseling in Drug Abuse Treatment
NCT ID: NCT00809445
Last Updated: 2015-10-14
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
1281 participants
INTERVENTIONAL
2009-01-31
2010-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Bundled Rapid HIV/HCV Testing Intervention to Increase Receipt of Test Results
NCT02355080
Behavioral Intervention Trial for HIV-infected Injection Drug Users
NCT00146445
Reduction of Drug Use and HIV Risk Among Out-of-Treatment Methamphetamine Users
NCT01161485
HIV Rapid Testing & Counseling in Sexually Transmitted Disease (STD) Clinics in the U.S.
NCT01154296
Reducing Co-occurring Substance Use and HIV Risk Among Stimulant-using Men at High Risk for HIV in the United States of America.
NCT07281378
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HIV rapid test & counseling
Participants will be offered an oral fluid HIV rapid test (via oral swab) and brief prevention counseling that addresses both risk reduction and motivation to be HIV tested based on an evidence-based counseling approach (Project RESPECT-2 counseling). Prior to receiving testing, study participants must first provide consent for HIV testing. Consent for testing will be obtained through a second consent form required of all participants who wish to proceed with the HIV test.
On-site HIV rapid test and brief, prevention counseling
Participants will be offered an on-site oral fluid HIV rapid test with brief prevention counseling that addresses both risk reduction and motivation to be HIV tested based on an evidence-based counseling approach.
HIV rapid test and info
Participants will be offered an oral fluid HIV rapid test (via oral swab). Prior to receiving testing, study participants must first provide consent for HIV testing. Again, consent for testing will be obtained through a second consent form required of all participants who wish to proceed with the HIV test. Participants will receive rapid HIV testing and test results after signing the consent to be tested. In both Groups 1 and 2, participants who test reactive (preliminary positive) will be counseled on the sexual risk behaviors associated with transmission of HIV and the acquisition of STDs, as is current clinical practice with those testing HIV positive. Confirmed positives will be linked to HIV primary care.
On- site HIV rapid test & information
Participants will be offered an on-site oral fluid HIV rapid test with basic info.
HIV testing referral
Participants randomized to group 3 will receive a referral list for HIV community-testing agencies. Each CTP site will have previously prepared an extensive referral list of testing sites in the surrounding geographic area. By virtue of their status as patients in the CTPs, they will receive whatever HIV testing and HIV education referrals the CTPs normally provide to their patients. This is the standard of care at CTPs that do not provide on-site testing.
Referral for off-site HIV testing
Participants will be offered a referral list of HIV testing agencies in the community.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
On-site HIV rapid test and brief, prevention counseling
Participants will be offered an on-site oral fluid HIV rapid test with brief prevention counseling that addresses both risk reduction and motivation to be HIV tested based on an evidence-based counseling approach.
On- site HIV rapid test & information
Participants will be offered an on-site oral fluid HIV rapid test with basic info.
Referral for off-site HIV testing
Participants will be offered a referral list of HIV testing agencies in the community.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* HIV-negative or HIV status unknown
* No receipt of results from HIV test initiated within last 12 months
* Be able to communicate in English
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
University of California, San Francisco
OTHER
University of Miami
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Daniel J Feaster
Associate Professor of Biostatistics
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lisa Metsch, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Columbia University
Grant Colfax, M.D.
Role: PRINCIPAL_INVESTIGATOR
PATH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
La Frontera Center, Inc.
Tucson, Arizona, United States
Midwestern Connecticut Council on Alcoholism
Danbury, Connecticut, United States
Wheeler Clinic
Plainville, Connecticut, United States
Glenwood Life Counseling Center
Baltimore, Maryland, United States
Gibson Recover Centers
Cape Girardeau, Missouri, United States
The Life Link
Santa Fe, New Mexico, United States
Daymark Recovery Services, Inc.
Salisbury, North Carolina, United States
CODA
Portland, Oregon, United States
Addiction Medicine Services (Western Psychiatric Institute)
Pittsburgh, Pennsylvania, United States
Morris Village Alcohol and Drug Treatment Center
Columbia, South Carolina, United States
Lexington / Richland Alcohol and Drug Abuse Council
Columbia, South Carolina, United States
Chesterfield CSB Substance Abuse Service
Chesterfield, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Metsch LR, Feaster DJ, Gooden L, Matheson T, Mandler RN, Haynes L, Tross S, Kyle T, Gallup D, Kosinski AS, Douaihy A, Schackman BR, Das M, Lindblad R, Erickson S, Korthuis PT, Martino S, Sorensen JL, Szapocznik J, Walensky R, Branson B, Colfax GN. Implementing rapid HIV testing with or without risk-reduction counseling in drug treatment centers: results of a randomized trial. Am J Public Health. 2012 Jun;102(6):1160-7. doi: 10.2105/AJPH.2011.300460. Epub 2012 Apr 19.
Schackman BR, Metsch LR, Colfax GN, Leff JA, Wong A, Scott CA, Feaster DJ, Gooden L, Matheson T, Haynes LF, Paltiel AD, Walensky RP. The cost-effectiveness of rapid HIV testing in substance abuse treatment: results of a randomized trial. Drug Alcohol Depend. 2013 Feb 1;128(1-2):90-7. doi: 10.1016/j.drugalcdep.2012.08.009. Epub 2012 Sep 9.
Schackman BR, Leff JA, Barter DM, DiLorenzo MA, Feaster DJ, Metsch LR, Freedberg KA, Linas BP. Cost-effectiveness of rapid hepatitis C virus (HCV) testing and simultaneous rapid HCV and HIV testing in substance abuse treatment programs. Addiction. 2015 Jan;110(1):129-43. doi: 10.1111/add.12754.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20080379
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.